WallStSmart
KALA

Kala Pharmaceuticals Inc

NASDAQ: KALA · HEALTHCARE · BIOTECHNOLOGY

$0.11
-3.93% today

Updated 2026-04-30

Market cap
$110.98M
P/E ratio
P/S ratio
23.75x
EPS (TTM)
$-3.31
Dividend yield
52W range
$0 – $21
Volume
9.1M

Kala Pharmaceuticals Inc (KALA) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+45.0%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+102.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-5.2%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-5.8%
2025-11-19
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-31$0.02$0.17$0.16-4.7%
2025-11-19$-1.07+61.9%$0.69$0.65-5.8%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$0.02
2025-09-30$-2.81$-1.07+61.9%
2025-06-30$-2.93$-1.71+41.6%
2025-03-31$-2.54$-1.74+31.4%
2024-12-31$-2.47$-1.23+50.1%$254000.00+262.9%
2024-09-30$-2.43$-1.93+20.4%
2024-06-30$-4.40$-3.16+28.2%
2024-03-31$-2.89$-4.19-45.0%
2023-12-31$-3.62$-3.18+12.2%$70000.00
2023-09-30$-2.15$-3.41-58.6%
2023-06-30$-3.19$-4.36-36.7%
2023-03-31$-4.52$-6.99-54.6%

Frequently asked questions

Has Kala Pharmaceuticals Inc beaten earnings estimates?
Kala Pharmaceuticals Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +45.0% over the last 3 quarters.
How does KALA stock react to earnings?
KALA stock has moved an average of -5.2% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.